Impaired EDHF-mediated vasodilation and function of endothelial Ca2+-activated K+ channels in uremic rats  by Kehler, Ralf et al.
Kidney International, Vol. 67 (2005), pp. 2280–2287
ION CHANNELS – MEMBRANE TRANSPORT – INTEGRATIVE PHYSIOLOGY
Impaired EDHF-mediated vasodilation and function of
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Impaired EDHF-mediated vasodilation and function of
endothelial Ca2+-activated K+ channels in uremic rats.
Background. Chronic renal failure (CRF) is associated with
increased cardiovascular morbidity, abnormal arterial tone, and
endothelial dysfunction. Ca2+-activated K+-channels (KCa) are
important regulators of endothelial function by controlling en-
dothelial hyperpolarization and thus endothelium-derived hy-
perpolarizing factor (EDHF)-meditated vasodilations. Here we
tested the hypothesis whether an altered function of endothelial
KCa and diminished EDHF-meditated vasodilation contribute
to the endothelial dysfunction in the rat remnant kidney model
of chronic renal failure.
Methods. Functional expression of endothelial KCa currents
and endothelium-dependent vasodilations in rat carotid arteries
were assessed by using patch-clamp techniques, single-cell re-
verse transcription-polymerase chain reaction (RT-PCR), and
a pressure myograph 8 weeks after either subtotal 5/6 nephrec-
tomy in normotensive or hypertensive, or sham-operated rats.
Results. Acetylcholine (ACh)-induced EDHF-mediated va-
sodilations were present in sham-operated rats, but almost
absent in both normotensive 5/6 nephrectomy rats and hyper-
tensive 5/6 nephrectomy rats. In experiments without block-
ing nitric oxide/prostacyclin synthesis, endothelium-dependent
vasodilation to ACh was significantly reduced in both nor-
motensive 5/6 nephrectomy rats and hypertensive 5/6 nephrec-
tomy rats. In sham-operated rats, 1-ethyl-2-benzimidazolinone
(1-EBIO), a selective opener of endothelial small and interme-
diate KCa, induced a substantial EDHF-mediated vasodilation,
which was greatly reduced in hypertensive 5/6 nephrectomy
rats and in normotensive 5/6 nephrectomy rats. In patch-clamp
experiments, mean KCa currents were significantly reduced in
endothelial cells from hypertensive 5/6 nephrectomy rats and
normotensive 5/6 nephrectomy rats when compared to sham-
operated rats. Concordantly, single-cell reverse-transcription-
polymerase chain reaction (RT-PCR) analysis revealed a greatly
reduced frequency of endothelial cells expressing the KCa genes,
SKCa3 and IKCa1 in 5/6 nephrectomy rats compared to sham-
operated rats.
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Conclusion. Experimental CRF leads to a loss of EDHF-type
vasodilation which was caused at least in part by an impaired
functional expression of endothelial hyperpolarizing KCa. The
loss of EDHF-type vasodilation may contribute to endothelial
dysfunction and abnormal arterial tone in CRF.
Patients with end-stage renal disease (ESRD) ex-
hibit increased cardiovascular morbidity due to an in-
creased risk of arteriosclerosis, abnormal regulation of
arterial tone, and hypertension [1, 2]. There is growing
evidence that chronic renal failure (CRF) is associated
with an impaired endothelial function and thus defective
endothelium-dependent vasodilation [3–6]. Endothelial
dysfunction is an early feature of vascular complications
in several diseases [7–10] such as hypertension, diabetes,
hypercholesterolemia, and coronary heart disease, al-
though the exact mechanism leading to endothelial dys-
function is not clear. In CRF, several pathogenic factors
like excessive generation of reactive oxygen species [1, 11,
12], hypertension [1], dyslipidemia with increased serum
levels of cytotoxic low-density lipoprotein (LDL) [11],
competitive inhibition of endothelial nitric oxide by in-
creased production by of endogeneous nitric oxide in-
hibitors such as asymmetrical dimethylarginine (ADMA)
[13] have been proposed to cause endothelial dysfunc-
tion. Also a diminished nitric oxide availability due to
nitric oxide inactivation by reactive oxygen species may
result in endothelial dysfunction [11, 14]. In addition
to an impaired nitric oxide production or nitric oxide
availability recent studies suggest that also the third va-
sodilatory system, the endothelium-derived hyperpolar-
ization factor (EDHF)-mediated vasodilation might be
disturbed in CRF [17, 18], which may contribute to the im-
paired endothelium-dependent vasodilation in patients
with CRF.
The EDHF-vasodilatory system is considered of ma-
jor importance in the regulation of vascular tone. For
instance, the EDHF system can compensate the loss of
the nitric oxide system as concluded from the conserved
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endothelium-dependent vasodilation and mild hyperten-
sion in endothelial nitric oxide synthase (eNOS)−/− mice
[19, 20]. Moreover, several studies suggested that the
EDHF system becomes as important as the nitric ox-
ide system or even more important when vessel size de-
creases [21]. Therefore, it seems that the EDHF system
plays a significant role in the regulation of resistance ar-
teries and thus the regulation of blood pressure.
Regarding the cellular mechanisms of EDHF-
mediated vasodilations, endothelial Ca2+-activated K+
channels (KCa) play a pivotal role [16, 22–24] by medi-
ating endothelial hyperpolarization and, especially, KCa
of small conductance (SKCa) encoded by the SKCa gene
SKCa3 (SK3 and KCa 2.3) and of intermediate conduc-
tance (IKCa) encoded by the IKCa gene IKCa1 (IK1,
KCNN4, and KCa3.1) have been shown to be the predom-
inant hyperpolarizing KCa channels expressed in human
and rat endothelium [23, 25, 26]. Their activation follow-
ing agonist stimulation resulting in endothelial hyperpo-
larization is considered a prerequisite for the initiation
of EDHF-type vasodilations [16] and, concordantly, se-
lective blockade of SKCa and IKCa channels suppresses
EDHF-mediated vasodilation in most vascular beds from
different species, including humans [16, 23]. The signal
transduction pathways of EDHF-signaling beyond en-
dothelial hyperpolarization are incompletely character-
ized [16]. Results of a large number of studies suggest
that endothelial hyperpolarization may be directly propa-
gated via gap junctions to the smooth muscle cells [16, 27].
Alternatively, K+ efflux from the endothelium through
endothelial SKCa and IKCa could stimulate inwardly
rectifying K+ channel and sodium/potassium adenosine
triphosphatases (Na/K ATPases) in vascular smooth mus-
cle cells (VSMCs) leading to VSMC hyperpolarization
and thus vasodilation [28]. Other proposed EDHFs such
as epoxyeicotrienic acids (EETs) may play a modulatory
role [16, 29].
In the present study we tested the hypothesis that
a decreased functional expression of endothelial KCa-
channels in CRF leads to an impairment of EDHF-
type vasodilation and is part of the endothelial dysfunc-
tion in CRF. In rats with CRF due to 5/6 nephrectomy,
we observed a severely impaired EDHF-mediated va-
sodilation, reduced expression of the endothelial KCa
genes SKCa3 and IKCa1, and reduced KCa functions in
carotid arteries from normotensive and hypertensive 5/6
nephrectomy rats.
METHODS
Animal studies and treatment protocols
Animal studies were approved by the local Animal
Care and Use Committee, Sprague-Dawley rats (350 to
450-g) were subjected to 5/6 nephrectomy (N = 17) or
sham operation (N = 7) as described previously [30].
The group of 5/6 nephrectomy rats was divided into
two subgroups from which one (N = 6) was subjected
to an antihypertensive triple drug treatment (a combi-
nation of reserpine 5 mg/L, hydralazine 80 mg/L, and
hydrochlorothiazide 25 mg/L, in the drinking water) start-
ing from day 1 after surgery. The other subgroup of 5/6
nephrectomy rats did not receive antihypertensive ther-
apy. Systolic blood pressure was monitored weekly in the
awake animals by the tail-cuff method. At the end of week
8, urine was collected for 24 hours and water consump-
tion was determined in metabolic cages. All rats were
sacrificed 8 weeks after surgery and left and right carotid
artery, heart, and kidneys were excised. For evaluation of
renal insufficiency in the 5/6 nephrectomy groups, levels
of urea and creatinine were determined in urine and/or
serum samples from all rats.
Patch-clamp experiments and single-cell reverse
transcription-polymerase chain reaction (RT-PCR)
experiments in endothelial cells of carotid artery
Single-cell RT-PCR analysis of KCa gene expression
in endothelial cells of carotid artery in situ, whole-cell
patch-clamp experiments, and data analysis were per-
formed as described previously [23, 25]. In brief, vessel
slices of freshly dissected carotid artery were mounted
on holding pipette and preincubated with 0.05% trypsin
and 0.02% ethylenediaminetetraacetic acid (EDTA) in
phosphate- buffered saline (PBS) without Ca2+/Mg2+ for
up to 15 minutes followed by wash out. For in situ har-
vesting of endothelial cells, a single endothelial cell was
selectively fixed with the patch pipette and mechanically
detached from the vessel wall. After RT of mRNA from
single endothelial cell sample, a “multiplex” single-cell
RT-PCR was performed using intron-spanning primer
pairs for the small- and intermediate-conductance KCa
genes, rSKCa3 and rIKCa1, and endothelial nitric oxide
synthase (reNOS) as endothelial cell marker. Sequences
of primer pairs are stated elsewhere [23, 25]. Mem-
brane currents in electrically isolated endothelial cells
were recorded with an EPC-9 (Heka; Lamprecht, Pfalz,
Germany) patch-clamp amplifier using voltage ramps
(duration 1000 mseconds) from −100 mV to +100 mV.
For activation of KCa currents, endothelial cells were di-
alyzed with a KCl pipette solution containing 3 lmol/L
[Ca2+]free.
Pressure myograph experiments
Pressure myograph experiments were performed as
desribed previously [23, 25]. In brief, carotid artery seg-
ments of 3 to 4 mm in length were cannulated with
micropipettes in an experimental chamber mounted on
the stage of a Zeiss Axiovert 100 (Oberkochen, Ger-
many). Vessel diameter was continuously monitored with
a video camera. The bath and perfusion solution con-
tained (in mmol/L): 145.0 NaCl, 1.2 NaH2PO4, 4.7 KCl,
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1.2 MgSO4, 2.0 CaCl2, 5.0 glucose, 2.0 pyruvate, and 3.0
3-[N-morpholine] propane sulfonic acid (MOPS) buffer
along with 1 g/100 mL bovine serum albumin (BSA) (pH
7.4) at 37◦C. To block nitric oxide and prostacyclin synthe-
sis the NOS inhibitor NG-nitro-L-arginine (L-NNA) (100
lmol/L) and the cyclooxygenase inhibitor indomethacin
(10 lmol/L) were added to both the bath and perfu-
sion solution. Carotid arteries were pressurized to 80 mm
Hg with a pressure myograph system (J.P. Trading P100,
Aarhus, Denmark) and continuously perfused at a flow
rate of 0.6 mL/min. After an initial equilibration period
for 40 minutes, carotid arteries were preconstricted with
1 lmol/L phenylephrine in the bath solution. After de-
velopment of stable tone, nitric oxide- and prostacyclin-
dependent and independent vasodilatory responses were
determined by perfusion with increasing concentrations
of acetylcholine (ACh) (1 nmol/L to 10 lmol/L). Diame-
ter changes are expressed as percentage of the maximal
vasodilation measured in response to 1 lmol/L sodium ni-
troprusside (SNP). The selective SKCa and IKCa opener,
1-ethyl-2-benzimidazolinone (1-EBIO) (100 lmol/L) was
made as 1000-fold stock solution in dimethyl sulfoxide
(DMSO) and was applied intraluminally. 1-EBIO was ob-
tained from Tocris (Ko¨ln, Germany); all other chemicals
were from Sigma Chemical Co. (St. Louis, MO, USA)
Statistical analysis
Data are given as mean ± SE. If appropriate, Student
t test or v 2 analyses were used to assess differences be-
tween groups. P values of P < 0.05 were considered sig-
nificant.
RESULTS
Renal insufficiency and systolic blood pressure in 5/6
nephrectomy rats
Data from laboratory tests and general characteris-
tics of both groups of 5/6 nephrectomy rats and of
sham-operated controls are summarized in Table 1. Un-
treated 5/6 nephrectomy rats developed severe hyper-
tension, whereas hypertension was prevented by the
antihypertensive therapy in 5/6 nephrectomy rats. In hy-
pertensive 5/6 nephrectomy rats and in normotensive
5/6 nephrectomy rats, serum concentrations of creati-
nine and urea were significantly increased and urine
concentration of creatinine was greatly reduced when
compared to sham-operated controls. Urine volume
and fluid intake were significantly increased in both
hypertensive 5/6 nephrectomy and normotensive 5/6
nephrectomy rats. Consequently, creatinine clearance
was greatly reduced in both 5/6 nephrectomy groups
which thus documents renal insufficiency in these rats.
In both 5/6 nephrectomy groups, the wet weight of the
remnant kidney was significantly higher than healthy
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Fig. 1. Defective endothelium-dependent
vasodilation in normotensive and hyper-
tensive uremic rats. (A) Impaired “total”
endothelium-dependent vasodilatory re-
sponses to acetylcholine (Ach) (1 nmol/L
to 10 lmol/L) in carotid arteries from
hypertensive 5/6 nephrectomy (5/6 NxH) ( )
(N = 11) and normotensive 5/6 nephrectomy
(5/6 NxN) (∇) (N = 4) and sham-operated
controls (Sham) () (N = 7) in the ab-
sence of nitric oxide synthase (NOS) and
cyclooxygenase inhibitors. (B) Impaired
endothelium-derived hyperpolarizing factor
(EDHF)-mediated vasodilatory responses
to ACh (1 nmol/L to 10 lmol/L) in carotid
arteries from hypertensive 5/6 nephrectomy
rats ( ) (N = 11) and normotensive 5/6
nephrectomy rats (∇) (N = 6) and sham-
operated rats () (N = 7) in the presence
of the NOS inhibitor NG-nitro-L-arginine
L-NNA (100 lmol/L) and the cyclooxygenase
inhibitor indomethacin (10 lmol/L).
kidneys of controls. Wet heart weight was significantly
enhanced only in the untreated hypertensive 5/6 nephrec-
tomy rats presumably as a consequence of hyperten-
sion, as heart weight was not significantly different in the
antihypertesive-treated normotensive 5/6 nephrectomy
rats.
Impaired endothelium-dependent vasodilation in nor-
motensive and hypertensive 5/6 nephrectomy rats
In carotid arteries, endothelium-dependent vasodila-
tion induced by ACh (1 nmol/L to 10 lmol/L) in the
absence of NOS and cyclooxygenase inhibitors was sig-
nificantly reduced in hypertensive 5/6 nephrectomy rats
when compared to sham-operated controls (Fig. 1A).
In the presence of NOS und cyclooxygenase inhibitors,
ACh induced a significant EDHF-mediated vasodila-
tion in the sham-operated controls, whereas in hyper-
tensive 5/6 nephrectomy, EDHF-mediated vasodilation
was almost absent (Fig. 1B). To rule out that the re-
duced “total” endothelium-dependent vasodilations and
the loss of EDHF-mediated vasodilation was solely a con-
sequence of the development of hypertension in these
uremic rats, we also tested endothelium-dependent va-
sodilatory responses in the normotensive 5/6 nephrec-
tomy rats. Similar to hypertensive 5/6 nephrectomy,
“total” endothelium-dependent vasodilation was signif-
icantly reduced and EDHF-mediated vasodilation was
severely impaired in the normotensive 5/6 nephrec-
tomy (Fig. 1). This indicates that defective endothelium-
dependent vasodilation in 5/6 nephrectomy rats appears
to be related to uremia and can not be attributed solely
to endothelial damage caused by hypertension in this
model.
Endothelium-independent responses to phenyle-
phrine and SNP were similar in pressurized
nonendothelium-denuded carotid arteries from hy-
pertensive 5/6 nephrectomy rats, normotensive 5/6
nephrectomy rats, and sham-operated controls (data not
shown), which indicates normal vascular smooth muscle
function in these uremic rats.
Impaired 1-EBIO–mediated vasodilation in normoten-
sive and hypertensive 5/6 nephrectomy rats
EDHF-mediated vasodilations in carotid arteries of
healthy rats and in other vascular beds of rats and other
species are closely related to the Ca2+-dependent ope-
nening of endothelial SKCa and IKCa channels leading
to endothelial hyperpolarization and thus vasodilation
[16, 22–24]. Consequently, EDHF-type vasodilations in
carotid arteries can also be mimicked by selective SKCa
and IKCa openers such as 1-EBIO [25, 31]. On the other
hand, EDHF-type vasodilation is abolished after selec-
tive inhibition of endothelial SKCa by apamin and IKCa
channels by TRAM-34 [32], as previously shown by us
[23].
To test whether the impaired EDHF-type vasodilation
observed in normotensive 5/6 nephrectomy and hyper-
tensive 5/6 nephrectomy rats was caused by endothelial
KCa dysfunction, we studied vasodilatory effects of the
selective SKCa and IKCa opener1-EBIO in normoten-
sive 5/6 nephrectomy rats, hypertensive 5/6 nephrec-
tomy rats, and sham-operated controls. Intraluminal ap-
plication of 1-EBIO induced a substantial vasodilation
of ≈ 20% in sham-operated controls (Fig. 2), whereas
1-EBIO-induced vasodilation was greatly reduced in
both normotensive 5/6 nephrectomy and hypertensive 5/6
nephrectomy rats (Fig. 2).
These data from pressure myograph measurements
strongly indicate that EDHF-mediated vasodilation is
severely impaired in this model of CRF.
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Fig. 2. Impaired endothelial hyperpolarization-mediated vasodilatory
responses to 1-ethyl-2-benzimidazolinone (1-EBIO) (100 lmol/L) in
carotid arteries from hypertensive 5/65 nephrectomy rats (5/6 NxH)
(N = 11) and normotensive 5/6 nephrectomy (5/6 NxN) (N = 6) and
sham-operated controls (Sham) (N = 7). Values are given as mean ±
SE. ∗P < 0.05; Student t test.
Alterations in Kca function and expression in endothelial
cells of normotensive and hypertensive 5/6 nephrectomy
rats
The finding of an impaired EDHF-mediated vasodi-
lation and especially of endothelial hyperpolarization-
mediated vasodilation induced by 1-EBIO might be
indicative of a decreased functional expression of the en-
dothelial KCa channels in hypertensive 5/6 nephrectomy
rats and normotensive 5/6 nephrectomy rats. To test this
hypothesis, we performed whole-cell patch-clamp experi-
ments in endothelial cells from hypertensive 5/6 nephrec-
tomy rats, normotensive 5/6 nephrectomy rats, and
sham-operated controls to determine the function of
SKCa and IKCa channels. To fully activate SKCa and IKCa
channels by Ca2+ in whole-cell patch-clamp experiments,
single endothelial cells were dialyzed with a pipette solu-
tion containing 3 lmol/L free Ca2+ [23], which is sufficient
for maximal channel activation (EC50 s 400 to 500 nmol/L
Ca2+) [26, 33–35]. The electrophysiologic and pharmaco-
logic properties of SKCa and IKCa channels in endothelial
cells of rat carotid arteries were described by us in more
detail previously [23, 26].
The whole-cell patch-clamp experiments revealed that
in endothelial cells from hypertensive 5/6 nephrectomy
rats and normotensive 5/6 nephrectomy rats, composite
SKCa and IKCa currents were significantly reduced by ≈
50% when compared to those in endothelial cells from
sham-operated controls. Original traces and mean com-
posite SKCa/IKCa currents normalized to cell capacitance
are shown in Figure 3.
Subsequent to patch-clamp experiments, we used
“multiplex” single-cell RT-PCR [22, 26] to determine
whether the decreased currents through SKCa and IKCa
channels in endothelial cells from hypertensive 5/6
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Fig. 3. Quantitative analysis of endothelial Ca2+-activated K+ cur-
rents in normotensive and hypertensive uremic rats. (A) Representa-
tive Ca2+-activated K+ currents (KCa) in endothelial cells from hyper-
tensive 5/6 nephrectomy rats (5/6 NxH) and sham-operated controls
(Sham). For activation of KCa in whole-cell patch-clamp experiments,
single endothelial cells were dialyzed with a high K+ pipette solution
(140 mmol/L) containing 3 lmol/L free Ca2+. High Na+ (142 mmol/L)
bath solution contained 4.5 mmol/L K+. Note that whole-cell currents
reverse at a holding potential near by the K+ equilibrium potential
(−89 mV) which indicates K+ selectivity of this current. (B) Reduced
KCa currents normalized to cell capacitance in endothelial cells from
hypertensive 5/6 nephrectomy () cells (N = 91) (from 11 rats), nor-
motensive 5/6 nephrectomy () cells (N = 27) (from four rats), and
from sham-operated controls (Sham) () (N = 46) (from seven rats).
Values are given as mean ± SE. ∗P < 0.01 hypertensive 5/6 nephrec-
tomy vs. sham; #P < 0.05; ##P < 0.01 normotensive 5/6 nephrectomy vs.
sham, Student t test.
nephrectomy rats correlated with alterations in mRNA
levels for the respective KCa genes SKCa3 [33] and IKCa1
[34, 35].
As shown in Figure 4, we detected SKCa3 and
IKCa1 mRNA in almost every endothelial cell sample
(SKCa3 100%, 18/18 endothelial cell samples; IKCa1
94%, 17/18 endothelial cell samples). In endothelial cells
from hypertensive 5/6 nephrectomy rats, the frequency
of endothelial cell samples containing SKCa3 and IKCa1
mRNAs was greatly reduced (SKCa3 45%, 9/20 endothe-
lial cell samples) (P =0.09, v 2 analyses) (IKCa1 25%, 5/20
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Fig. 4. Diminished KCa gene expression in endothelial cells from in hy-
pertensive uremic rats. Ethidium bromide–stained gels of “multiplex”
single-cell reverse transcription-polymerase chain reaction (RT-PCR)
products of the endothelial KCa genes SKCa3 and IKCa1 from single
endothelial cell samples from sham-operated controls (upper panel)
and from hypertensive 5/6 nephrectomy rats (5/6 Nx) (lower panel).
The upper panel shows RT-PCR products from seven single endothe-
lial cells from sham-operated controls (Sham), one medium sample
control and one nontemplate control (H2O). The lower panel shows
RT-PCR products from nine single endothelial cells from hypertensive
5/6 nephrectomy rats. Note the high frequency of endothelial cells from
5/6 nephrectomy rats in which neither SKCa3 nor IKCa1 mRNA ex-
pression was detected.
endothelial cell samples) (P < 0.05, v 2 analyses). In addi-
tion, SKCa3 and/or IKCa1 could not be detected in 9/20
endothelial cell samples (P < 0.05 vs. controls, v 2 anal-
yses), whereas in all endothelial cell samples (N = 18)
from sham-operated controls mRNAs of SKCa3 and/or
IKCa1 mRNAs, mostly of both channels and rarely of
only SKCa3 (N = 1), were detected (Fig. 4). The find-
ing of a decreased frequency of endothelial cell samples
from 5/6 nephrectomy rats containing mRNAs of these
two KCa genes suggests that the reduced KCa currents
in endothelial cells from 5/6 nephrectomy rats might be
caused by a diminished basal expression of these two KCa
genes.
On the whole, the diminished functional expression of
these two endothelial KCa genes might lead to a decreased
ability of the endothelium to hyperpolarize in response
to agonist stimulation. This in turn could explain the loss
of ACh-induced EDHF-mediated vasodilation and the
reduced vasodilatory response to the selective SKCa/IKCa
opener 1-EBIO in normotensive 5/6 nephrectomy and
hypertensive 5/6 nephrectomy rats.
DISCUSSION
Using the 5/6 nephrectomy rat model of CRF, we pro-
vide evidence that the EDHF-vasodilatory system is im-
paired in CRF. This is based on the observation that
EDHF-mediated vasodilation induced by agonist stimu-
lation or pharmacologically is severely reduced in uremic
rats. With respect to the underlying cellular mechanism,
we show that function and mRNA expression of endothe-
lial KCa channel, which are a prerequiste for the initia-
tion of the EDHF response [16], are reduced in uremic
rats. Therefore, the loss of endothelial KCa channel func-
tions and the subsequently diminished EDHF-mediated
vasodilation could be a component of endothelial dys-
function in CRF.
Endothelial dysfunction is a general characteristic of
patients with ESRD, but the underlying pathophysiologic
mechanisms are poorly understood [1–5]. In addition, it
is not clear whether this endothelial dysfunction is a di-
rect consequence of an accumulation of uremic toxins
or secondary to hypertension in these patients. In recent
years, it has been postulated that endothelial dysfunction
and thus defective regulation of vascular tone might be
caused by either a disturbed nitric oxide production due
to decreased expression levels of the endothelial NOS
isoform [36] or by diminished nitric oxide availability due
to nitric oxide scavenging and inactivation by increased
levels of reactive oxygen species [2, 11, 12]. Also an in-
crease in the level of endogeneous nitric oxide inhibitors
has been proposed to hamper endothelial nitric oxide
production in CRF [13]. In the present study we found
that ACh-induced endothelium-dependent vasodilation
in the absence of nitric oxide/prostacyclin inhibitors was
significantly reduced in uremic rats which may indicate di-
minished nitric oxide production or availability in these
uremic rats.
The inhibition of nitric oxide/prostacyclin synthesis re-
sulted in a reduced ACh-induced vasodilating response
in healthy rats, but in an almost complete loss of ACh-
induced vasodilations in uremic rats. This finding may
also imply that the putative impairment of nitric oxide- or
prostacyclin-mediated vasodilations is not compensated
by the third vasodilatory system, the EDHF system which
have been proposed to act as an important backup system
when nitric oxide production is impaired [19, 37]. An al-
ternative interpretation of the data might be that impair-
ment of “total” ACh-induced endothelium-dependent
vasodilation was caused by a loss of the EDHF system
alone. This alternative interpretation assumes that EDHF
system contributes to “total” endothelium-dependent va-
sodilation even in the presence of the other two va-
sodilating factors. Noteworthy, in healthy rats, selective
blockers of endothelial hyperpolarizing KCa channels [23,
32], which are prerequisite for the generation of the
EDHF response [16, 22–28], reduce “total” endothelium-
dependent vasodilation to a level similar to that observed
in uremic rats [23].
Despite the large number of studies investigating the
nitric oxide system in CRF, only little attention has
been given to the EDHF system so far. However, data
from some studies already indicated that the EDHF-
vasodilatory system may play a role in endothelial dys-
function observed in human or experimental CRF [17,
18]. In the present study we show that the ACh-induced
EDHF-mediated vasodilation is severely impaired in
carotid arteries of uremic rats. Moreover, a vasodilatory
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response to endothelial hyperpolarization elicited by di-
rect pharmacologic opening of endothelial SKCa and
IKCa channels was greatly reduced in the uremic rats.
Since activation of these endothelial SKCa and IKCa chan-
nels is also of crucial importance in the initiation of the
EDHF signal following agonist stimulation [16, 22–28],
the defective EDHF-mediated vasodilation as well as
the impaired endothelial hyperpolarization-mediated va-
sodilation might thus be caused by a loss of these hy-
perpolarizing KCa channels in the endothelium. This in-
terpretation was further supported by the results of our
electrophysiologic studies which demonstrate a signifi-
cant reduction of SKCa and IKCa currents in endothelial
cells from uremic rats. This impaired function of SKCa and
IKCa channels might be explained by a reduced mRNA
expression of the respective KCa genes SKCa3 and IKCa1
as revealed by our single-cell RT-PCR experiments. How-
ever, the mechansim by which CRF may lead to a down-
regulation of endothelial expression of SKCa3 and IKCa1
remains to be clarified. Interestingly, a similar loss of en-
dothelial SKCa and IKCa channels as result of a decreased
SKCa3 and IKCa1 gene expression and consequently a
loss of EDHF-mediated vasodilation have been shown to
occur also in the regenerated endothelium after balloon
catheter angioplasty [25]. Thus it is tempting to specu-
late that a defective functional expression of endothelial
SKCa and IKCa channels might represent a more general
feature of endothelial dysfunction although the underly-
ing pathogenic process or cardiovascular disease states
may be different.
Hypertension has been reported to cause endothe-
lial dysfunction and more recently also EDHF-mediated
vasodilation in a model of experimental hypertension
[38]. To rule out that the defective EDHF-mediated
vasodilation was caused by hypertension in uremic
rats, we determined EDHF-mediated vasodilation in
normotensive uremic rats subjected to antihyperten-
sive therapy. We found that the antihypertensive treat-
ment did not prevent the loss of functional IKCa and
SKCa expression as well as the impairment of EDHF-
mediated vasodilation. Correspondingly, the endothelial
hyperpolarization-mediated vasodilation induced by di-
rect pharmacological openening of IKCa and SKCa chan-
nels was similarly impaired in normotensive uremic rats.
Thus these findings indicate that the impaired EDHF-
mediated vasodilation in carotid arteries of 5/6 nephrec-
tomy rats appears to be related to uremia but not solely
to the development of hypertension.
CONCLUSION
The present study revealed an impaired
EDHF-mediated vasodilation and endothelium
hyperpolarization-mediated vasodilation in a rat
model of CRF which was presumably caused by a loss of
functional IKCa and SKCa expression in the endothelium.
An improvement of endothelial EDHF function could
be benefical in preventing endothelial dysfunction and
thus abnormal regulation vascular tone in patient with
ESRD.
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